According to Allogene Therapeutics 's latest financial reports the company's current revenue (TTM ) is -HK$0.18 Million. In 2023 the company made a revenue of HK$0.23 Million a decrease over the revenue in the year 2022 that were of HK$1.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.